Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
- PMID: 32581217
- PMCID: PMC7314768
- DOI: 10.1038/s41467-020-16954-7
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
Abstract
The COVID-19 disease caused by the SARS-CoV-2 coronavirus has become a pandemic health crisis. An attractive target for antiviral inhibitors is the main protease 3CL Mpro due to its essential role in processing the polyproteins translated from viral RNA. Here we report the room temperature X-ray structure of unliganded SARS-CoV-2 3CL Mpro, revealing the ligand-free structure of the active site and the conformation of the catalytic site cavity at near-physiological temperature. Comparison with previously reported low-temperature ligand-free and inhibitor-bound structures suggest that the room temperature structure may provide more relevant information at physiological temperatures for aiding in molecular docking studies.
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment in
-
Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals.Structure. 2020 Dec 1;28(12):1313-1320.e3. doi: 10.1016/j.str.2020.10.007. Epub 2020 Oct 23. Structure. 2020. PMID: 33152262 Free PMC article.
Similar articles
-
Room-temperature neutron and X-ray data collection of 3CL Mpro from SARS-CoV-2.Acta Crystallogr F Struct Biol Commun. 2020 Oct 1;76(Pt 10):483-487. doi: 10.1107/S2053230X20011814. Epub 2020 Sep 15. Acta Crystallogr F Struct Biol Commun. 2020. PMID: 33006576 Free PMC article.
-
Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.Molecules. 2020 Aug 27;25(17):3920. doi: 10.3390/molecules25173920. Molecules. 2020. PMID: 32867349 Free PMC article. Review.
-
Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.Virus Res. 2020 Oct 15;288:198102. doi: 10.1016/j.virusres.2020.198102. Epub 2020 Jul 24. Virus Res. 2020. PMID: 32717346 Free PMC article.
-
Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (Mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation.Biophys Chem. 2020 Sep;264:106425. doi: 10.1016/j.bpc.2020.106425. Epub 2020 Jul 6. Biophys Chem. 2020. PMID: 32663708 Free PMC article.
-
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.ACS Comb Sci. 2020 Jun 8;22(6):297-305. doi: 10.1021/acscombsci.0c00058. Epub 2020 May 27. ACS Comb Sci. 2020. PMID: 32402186 Review.
Cited by
-
Fluorine Atoms on C6H5-Corrole Affect the Interaction with Mpro and PLpro Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches.Int J Mol Sci. 2022 Sep 19;23(18):10936. doi: 10.3390/ijms231810936. Int J Mol Sci. 2022. PMID: 36142848 Free PMC article.
-
Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites.Cell Host Microbe. 2022 Oct 12;30(10):1354-1362.e6. doi: 10.1016/j.chom.2022.08.003. Epub 2022 Aug 11. Cell Host Microbe. 2022. PMID: 36029764 Free PMC article.
-
Inhibition of SARS-CoV-2 main protease: a repurposing study that targets the dimer interface of the protein.J Biomol Struct Dyn. 2022 Sep;40(15):7167-7182. doi: 10.1080/07391102.2021.1910571. Epub 2021 Apr 13. J Biomol Struct Dyn. 2022. PMID: 33847241 Free PMC article.
-
SARS-CoV-2 proteins structural studies using synchrotron radiation.Biophys Rev. 2023 Sep 29;15(5):1185-1194. doi: 10.1007/s12551-023-01153-7. eCollection 2023 Oct. Biophys Rev. 2023. PMID: 37974992 Free PMC article. Review.
-
Elucidation of Binding Features and Dissociation Pathways of Inhibitors and Modulators in SARS-CoV-2 Main Protease by Multiple Molecular Dynamics Simulations.Molecules. 2022 Oct 12;27(20):6823. doi: 10.3390/molecules27206823. Molecules. 2022. PMID: 36296416 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
